This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
INNOHEP
LEO PHARMA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of INNOHEP in Canada?
A shortage of INNOHEP 20000UNIT is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 7, 2026), but it has not started yet.
Why is INNOHEP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will INNOHEP be available again?
The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02229515
Strength
20000UNIT
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
TINZAPARIN SODIUM
Tier
Unrated
Last Updated
2026-07-10
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
INNOHEP has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from LEO PHARMA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02540193
150MG · DIN 02521288
20MG · DIN 02560704
DIN 02319012
DIN 02244126
50MCG · DIN 01976133
50MCG · DIN 02150956
DIN 02457393
15% · DIN 02270811
DIN 02474883
2% · DIN 00586668
DIN 02238578